DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Europe Market Report for Dental Barrier Membranes 2017 - MedCore" report to their offering.
Research in terms of guided bone regeneration (GBR) is evidenced based on clinical trials. Dental barrier membranes on the market fulfill design criteria relevant for GBR. Both resorbable and non-resorbable membranes are available on the European market.
The market for barrier membranes is benefiting from increased consumer awareness and knowledge on the proven benefits of its use in regenerative procedures. Resorbable membranes offer the advantage of being resorbed by the body and thus eliminate the necessity of a second-stage surgery for removal.
For this reason, resorbable membranes appeal to both the dental clinician and patient as it reduces the risk of morbidity, tissue damage and time required to complete each procedure. These benefits can be attributed to the transition from non-resorbable to resorbable membranes. In 2016, resorbable membranes represented approximately 95% of the total volume of barrier membranes sold across Europe.
Key Topics Covered:
1. Research Methodology
2. Disease Overview
2.1 Basic Anatomy
2.2 Disease Pathology And Disorders
2.3 Patient Demographics
3. Product Assessment
3.1 Product Portfolios
3.2 Regulatory Issues And Recalls
3.3 Clinical Trials
4. Country Profiles
5. Dental Barrier Membrane Market
5.2 Market Overview
5.3 Market Analysis And Forecast
5.4 Drivers And Limiters
5.5 Competitive Market Share Analysis
- Botiss Biomaterials
- Zimmer Biomet
- ACE Surgical
- Non-Profit Tissue Banks
- Tecnoss Dental
For more information about this report visit http://www.researchandmarkets.com/research/p4tb4x/europe_market